183 related articles for article (PubMed ID: 10549305)
1. The GH receptor and GH insensitivity.
Ross RJ
Growth Horm IGF Res; 1999 Jun; 9 Suppl B():42-5; discussion 45-6. PubMed ID: 10549305
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction.
Milward A; Metherell L; Maamra M; Barahona MJ; Wilkinson IR; Camacho-Hübner C; Savage MO; Bidlingmaier M; Clark AJ; Ross RJ; Webb SM
J Clin Endocrinol Metab; 2004 Mar; 89(3):1259-66. PubMed ID: 15001620
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.
Iida K; Takahashi Y; Kaji H; Nose O; Okimura Y; Abe H; Chihara K
J Clin Endocrinol Metab; 1998 Feb; 83(2):531-7. PubMed ID: 9467570
[TBL] [Abstract][Full Text] [Related]
4. Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?
Amit T; Youdim MB; Hochberg Z
J Clin Endocrinol Metab; 2000 Mar; 85(3):927-32. PubMed ID: 10720017
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone receptor: structure and signal transduction.
Postel-Vinay MC; Finidori J
Eur J Endocrinol; 1995 Dec; 133(6):654-9. PubMed ID: 8548048
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH) insensitivity and insulin-like growth factor-I deficiency in Inuit subjects and an Ecuadorian cohort: functional studies of two codon 180 GH receptor gene mutations.
Fang P; Girgis R; Little BM; Pratt KL; Guevara-Aguirre J; Hwa V; Rosenfeld RG
J Clin Endocrinol Metab; 2008 Mar; 93(3):1030-7. PubMed ID: 18073295
[TBL] [Abstract][Full Text] [Related]
7. Primary GH insensitivity '(Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I.
Besson A; Salemi S; Eblé A; Joncourt F; Gallati S; Jorge AA; Mullis PE
Eur J Endocrinol; 2004 May; 150(5):635-42. PubMed ID: 15132718
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of truncated growth hormone (GH) receptor-(1-277) causing partial GH insensitivity syndrome with high GH-binding protein.
Iida K; Takahashi Y; Kaji H; Takahashi MO; Okimura Y; Nose O; Abe H; Chihara K
J Clin Endocrinol Metab; 1999 Mar; 84(3):1011-6. PubMed ID: 10084588
[TBL] [Abstract][Full Text] [Related]
9. Reduced proteolysis of rabbit growth hormone (GH) receptor substituted with mouse GH receptor cleavage site.
Wang X; He K; Gerhart M; Jiang J; Paxton RJ; Menon RK; Black RA; Baumann G; Frank SJ
Mol Endocrinol; 2003 Oct; 17(10):1931-43. PubMed ID: 12829808
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of inherited growth hormone resistance in childhood.
Amselem S; Sobrier ML; Dastot F; Duquesnoy P; Duriez B; Goossens M
Baillieres Clin Endocrinol Metab; 1996 Jul; 10(3):353-69. PubMed ID: 8853444
[TBL] [Abstract][Full Text] [Related]
11. The D152H mutation found in growth hormone insensitivity syndrome impairs expression and function of human growth hormone receptor but is silent in rat receptor.
Esposito N; Wojcik J; Chomilier J; Martini JF; Kelly PA; Finidori J; Postel-Vinay MC
J Mol Endocrinol; 1998 Aug; 21(1):61-72. PubMed ID: 9723864
[TBL] [Abstract][Full Text] [Related]
12. Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature.
Andrews A; Cottrell E; Maharaj A; Ladha T; Williams J; Schilbach K; Kaisinger LR; Perry JRB; Metherell LA; McCormick PJ; Storr HL
Eur J Endocrinol; 2023 Apr; 188(4):353-365. PubMed ID: 36943306
[TBL] [Abstract][Full Text] [Related]
13. Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation.
Yang N; Wang X; Jiang J; Frank SJ
Mol Endocrinol; 2007 Jul; 21(7):1642-55. PubMed ID: 17456794
[TBL] [Abstract][Full Text] [Related]
14. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein.
Ross RJ; Esposito N; Shen XY; Von Laue S; Chew SL; Dobson PR; Postel-Vinay MC; Finidori J
Mol Endocrinol; 1997 Mar; 11(3):265-73. PubMed ID: 9058373
[TBL] [Abstract][Full Text] [Related]
15. Metalloprotease-mediated GH receptor proteolysis and GHBP shedding. Determination of extracellular domain stem region cleavage site.
Wang X; He K; Gerhart M; Huang Y; Jiang J; Paxton RJ; Yang S; Lu C; Menon RK; Black RA; Baumann G; Frank SJ
J Biol Chem; 2002 Dec; 277(52):50510-9. PubMed ID: 12403792
[TBL] [Abstract][Full Text] [Related]
16. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
17. Blockade of growth hormone receptor shedding by a metalloprotease inhibitor.
Alele J; Jiang J; Goldsmith JF; Yang X; Maheshwari HG; Black RA; Baumann G; Frank SJ
Endocrinology; 1998 Apr; 139(4):1927-35. PubMed ID: 9528979
[TBL] [Abstract][Full Text] [Related]
18. Phenotype: genotype relationships in growth hormone insensitivity syndrome.
Woods KA; Dastot F; Preece MA; Clark AJ; Postel-Vinay MC; Chatelain PG; Ranke MB; Rosenfeld RG; Amselem S; Savage MO
J Clin Endocrinol Metab; 1997 Nov; 82(11):3529-35. PubMed ID: 9360502
[TBL] [Abstract][Full Text] [Related]
19. A 36 residues insertion in the dimerization domain of the growth hormone receptor results in defective trafficking rather than impaired signaling.
Maamra M; Milward A; Esfahani HZ; Abbott LP; Metherell LA; Savage MO; Clark AJ; Ross RJ
J Endocrinol; 2006 Feb; 188(2):251-61. PubMed ID: 16461551
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester- and growth factor-induced growth hormone (GH) receptor proteolysis and GH-binding protein shedding: relationship to GH receptor down-regulation.
Guan R; Zhang Y; Jiang J; Baumann CA; Black RA; Baumann G; Frank SJ
Endocrinology; 2001 Mar; 142(3):1137-47. PubMed ID: 11181529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
